166 related articles for article (PubMed ID: 23458688)
41. Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy.
Ren G; Adamus G
J Autoimmun; 2004 Sep; 23(2):161-7. PubMed ID: 15324934
[TBL] [Abstract][Full Text] [Related]
42. Serum antibody signature directed against Candida albicans Hsp90 and enolase detects invasive candidiasis in non-neutropenic patients.
Pitarch A; Nombela C; Gil C
J Proteome Res; 2014 Nov; 13(11):5165-84. PubMed ID: 25377742
[TBL] [Abstract][Full Text] [Related]
43. Antibodies against human muscle enolase recognize a 45-kDa bacterial cell wall outer membrane enolase-like protein.
Witkowska D; Pietkiewicz J; Szostko B; Danielewicz R; Masłowski L; Gamian A
FEMS Immunol Med Microbiol; 2005 Jul; 45(1):53-62. PubMed ID: 15985223
[TBL] [Abstract][Full Text] [Related]
44. Pituitary autoantibodies in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
O'Dwyer DT; McElduff P; Peterson P; Perheentupa J; Crock PA
Acta Biomed; 2007; 78 Suppl 1():248-54. PubMed ID: 17465338
[TBL] [Abstract][Full Text] [Related]
45. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
46. In situ distribution of enolase isozymes in chronic liver disease.
Fukuda Y; Miyazawa Y; Imoto M; Koyama Y; Nakano I; Nagura H; Kato K
Am J Gastroenterol; 1989 Jun; 84(6):601-5. PubMed ID: 2729230
[TBL] [Abstract][Full Text] [Related]
47. Course of serum autoantibodies in patients after acute angle-closure glaucoma attack.
Lorenz K; Beck S; Keilani MM; Wasielica-Poslednik J; Pfeiffer N; Grus FH
Clin Exp Ophthalmol; 2017 Apr; 45(3):280-287. PubMed ID: 27758063
[TBL] [Abstract][Full Text] [Related]
48. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1.
Clemente MG; Obermayer-Straub P; Meloni A; Strassburg CP; Arangino V; Tukey RH; De Virgiliis S; Manns MP
J Clin Endocrinol Metab; 1997 May; 82(5):1353-61. PubMed ID: 9141515
[TBL] [Abstract][Full Text] [Related]
49. Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung disease.
Terrier B; Tamby MC; Camoin L; Guilpain P; Bérezné A; Tamas N; Broussard C; Hotellier F; Humbert M; Simonneau G; Guillevin L; Mouthon L
Ann Rheum Dis; 2010 Feb; 69(2):428-33. PubMed ID: 19293162
[TBL] [Abstract][Full Text] [Related]
50. Novel autoantigens in autoimmune hypophysitis.
Lupi I; Broman KW; Tzou SC; Gutenberg A; Martino E; Caturegli P
Clin Endocrinol (Oxf); 2008 Aug; 69(2):269-78. PubMed ID: 18194487
[TBL] [Abstract][Full Text] [Related]
51. Purification of native alpha-enolase from Streptococcus pneumoniae that binds plasminogen and is immunogenic.
Whiting GC; Evans JT; Patel S; Gillespie SH
J Med Microbiol; 2002 Oct; 51(10):837-843. PubMed ID: 12435062
[TBL] [Abstract][Full Text] [Related]
52. Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders.
Cho SB; Lee JH; Ahn KJ; Cho S; Park YB; Lee SK; Bang D; Lee KH
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S31-8. PubMed ID: 20868568
[TBL] [Abstract][Full Text] [Related]
53. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
54. Streptococcus sanguinis and the sera of patients with Behçet's disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells.
Cho S; Zheng Z; Cho SB; Choi MJ; Lee KH; Bang D
Arch Dermatol Res; 2013 Apr; 305(3):223-32. PubMed ID: 23131860
[TBL] [Abstract][Full Text] [Related]
55. Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.
Johnson ME; Grassetti AV; Taroni JN; Lyons SM; Schweppe D; Gordon JK; Spiera RF; Lafyatis R; Anderson PJ; Gerber SA; Whitfield ML
Arthritis Res Ther; 2016 Jan; 18():27. PubMed ID: 26801089
[TBL] [Abstract][Full Text] [Related]
56. Autoantibodies to a group of centrosomal proteins in human autoimmune sera reactive with the centrosome.
Mack GJ; Rees J; Sandblom O; Balczon R; Fritzler MJ; Rattner JB
Arthritis Rheum; 1998 Mar; 41(3):551-8. PubMed ID: 9506584
[TBL] [Abstract][Full Text] [Related]
57. A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections.
Rodríguez E; Romarís F; Lorenzo S; Moreno J; Bonay P; Ubeira FM; Gárate T
Med Microbiol Immunol; 2006 Mar; 195(1):1-10. PubMed ID: 16049725
[TBL] [Abstract][Full Text] [Related]
58. Do autoantibodies predict autoimmune liver disease in primary Sjögren's syndrome? Data of 180 patients upon a 5 year follow-up.
Csepregi A; Szodoray P; Zeher M
Scand J Immunol; 2002 Dec; 56(6):623-9. PubMed ID: 12472675
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylated alpha-enolase induces autoantibodies in HLA-DR8 pancreatic cancer patients and triggers HLA-DR8 restricted T-cell activation.
Capello M; Caorsi C; Bogantes Hernandez PJ; Dametto E; Bertinetto FE; Magistroni P; Rendine S; Amoroso A; Novelli F
Immunol Lett; 2015 Sep; 167(1):11-6. PubMed ID: 26096821
[TBL] [Abstract][Full Text] [Related]
60. Serum level of anti-α-enolase antibody in untreated systemic lupus erythematosus patients correlates with 24-hour urine protein and D-dimer.
Li M; Li J; Wang J; Li Y; Yang P
Lupus; 2018 Jan; 27(1):139-142. PubMed ID: 28728510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
